Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | EVP, Regional Businesses | March 04, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date March 04, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,122 |
Ending reported balance
After 2026-03-05 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-03-04 · Grant · Acquired 11,364 · Balance 78,486 F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Row 2 · 2026-03-04 · Tax withholding · Disposed 5,806 · Balance 72,680 F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Row 3 · 2026-03-05 · Sale · Disposed 5,558 · Balance 67,122 F3: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. |
| Common StockSEC Table I · non-derivative | Indirect401(k)/SDCP | 4,502 |
Reported balance
Holding disclosure · report date 2026-03-04 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 4,502 F4: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.
F3: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
F4: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2023 Filed Feb 27, 2023 21:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 962 | $147.86 | $142,241.32 |
DisclosureSEC source: 0001022079-23-000030 · wf-form4_167753410682903.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,771 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| November 28, 2022 Filed Nov 29, 2022 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 40,765 | $86.63 Strike: $86.63 | $3,531,471.95 |
DisclosureSEC source: 0001022079-22-000168 · wf-form4_166975769075521.xml · derivative · entry 5 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,765 shares Expires 2029-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 27, 2022. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022. Read SEC document |
| November 28, 2022 Filed Nov 29, 2022 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 23,407 | $149.37 | $3,496,390.20 |
DisclosureSEC source: 0001022079-22-000168 · wf-form4_166975769075521.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,733 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 27, 2022. F3 · price: This transaction was executed in multiple trades at prices ranging from $149.120 to $149.860. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 28, 2022 Filed Nov 29, 2022 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 17,358 | $148.92 | $2,584,871.78 |
DisclosureSEC source: 0001022079-22-000168 · wf-form4_166975769075521.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,140 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 27, 2022. F2 · price: This transaction was executed in multiple trades at prices ranging from $148.120 to $149.110. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 28, 2022 Filed Nov 29, 2022 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 40,765 | $86.63 | $3,531,471.95 |
DisclosureSEC source: 0001022079-22-000168 · wf-form4_166975769075521.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 27, 2022. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 21:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 7,032 | $135.21 | $950,796.72 |
DisclosureSEC source: 0001022079-22-000054 · wf-form4_164686200422046.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,733 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 6,360 | $130.09 | $827,372.40 |
DisclosureSEC source: 0001022079-22-000054 · wf-form4_164686200422046.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,765 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 13,392 | $130.09 | $1,742,165.28 |
DisclosureSEC source: 0001022079-22-000054 · wf-form4_164686200422046.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,125 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:50 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 16,155 | $0.00 Strike: $127.73 | $0.00 |
DisclosureSEC source: 0001022079-22-000039 · wf-form4_164609580400204.xml · derivative · entry 4 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,155 Underlying: Common Stock · 16,155 shares Expires 2032-02-24 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:50 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 3,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000039 · wf-form4_164609580400204.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,733 F2 · security: Represents an award of restricted share units. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:50 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,750 | $126.26 | $347,215.00 |
DisclosureSEC source: 0001022079-22-000039 · wf-form4_164609580400204.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,405 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 00:05 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 492 | $130.23 | $64,073.16 |
DisclosureSEC source: 0001022079-22-000015 · wf-form4_164583391573361.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,155 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 00:05 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,082 | $130.09 | $140,757.38 |
DisclosureSEC source: 0001022079-22-000015 · wf-form4_164583391573361.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,647 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 37,565 | $95.80 Strike: $95.80 | $3,598,539.18 |
DisclosureSEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · derivative · entry 8 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,565 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021. F8 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 14,575 | $157.53 | $2,296,043.48 |
DisclosureSEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 6 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,729 F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021. F6 · price: This transaction was executed in multiple trades at prices ranging from $157.27 to $158.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 15,908 | $156.86 | $2,495,249.34 |
DisclosureSEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 5 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,304 F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021. F5 · price: This transaction was executed in multiple trades at prices ranging from $156.27 to $157.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 3,532 | $155.77 | $550,193.77 |
DisclosureSEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 4 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,212 F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021. F4 · price: This transaction was executed in multiple trades at prices ranging from $155.26 to $156.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 3,250 | $154.79 | $503,074.00 |
DisclosureSEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,744 F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $154.21 to $155.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 300 | $153.38 | $46,014.90 |
DisclosureSEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,994 F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $153.21 to $153.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 37,565 | $95.80 | $3,598,539.18 |
DisclosureSEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 8,536 | $139.96 | $1,194,724.17 |
DisclosureSEC source: 0001022079-21-000077 · wf-form4_162076480079936.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,729 F1 · price: This transaction was executed in multiple trades at prices ranging from $139.56 to $140.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 5,066 | $115.42 | $584,717.72 |
DisclosureSEC source: 0001022079-21-000052 · wf-form4_161549789475673.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,265 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 11,299 | $115.42 | $1,304,130.58 |
DisclosureSEC source: 0001022079-21-000052 · wf-form4_161549789475673.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,331 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 524 | $121.19 | $63,503.56 |
DisclosureSEC source: 0001022079-21-000038 · wf-form4_161428858488018.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,032 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 796 | $121.15 | $96,435.40 |
DisclosureSEC source: 0001022079-21-000038 · wf-form4_161428858488018.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,556 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted share units. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 22,105 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000017 · wf-form4_161378478948480.xml · derivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,105 Underlying: Common Stock · 22,105 shares Expires 2031-02-17 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 3,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000017 · wf-form4_161378478948480.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,352 F1 · security: Represents an award of restricted share units. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 58,392 | $66.51 Strike: $66.51 | $3,883,651.92 |
DisclosureSEC source: 0001022079-20-000164 · wf-form4_159925068530041.xml · derivative · entry 5 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,392 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2020. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 3,776 | $111.13 | $419,615.55 |
DisclosureSEC source: 0001022079-20-000164 · wf-form4_159925068530041.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,411 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $111.00 to $111.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 54,616 | $110.57 | $6,038,727.27 |
DisclosureSEC source: 0001022079-20-000164 · wf-form4_159925068530041.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,187 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $110.00 to $110.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 58,392 | $66.51 | $3,883,651.92 |
DisclosureSEC source: 0001022079-20-000164 · wf-form4_159925068530041.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2020. Read SEC document |
| March 11, 2020 Filed Mar 12, 2020 20:57 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,501 | $104.25 | $260,729.25 |
DisclosureSEC source: 0001022079-20-000073 · wf-form4_158404662542081.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,411 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:57 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 2,517 | $106.46 | $267,959.82 |
DisclosureSEC source: 0001022079-20-000073 · wf-form4_158404662542081.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,912 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:57 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 5,018 | $106.46 | $534,216.28 |
DisclosureSEC source: 0001022079-20-000073 · wf-form4_158404662542081.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,429 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2017, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 22:51 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 789 | $109.02 | $86,016.78 |
DisclosureSEC source: 0001022079-20-000061 · wf-form4_158293029573669.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,411 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 22:51 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 777 | $112.90 | $87,723.30 |
DisclosureSEC source: 0001022079-20-000061 · wf-form4_158293029573669.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,200 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 22:51 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 368 | $111.09 | $40,881.12 |
DisclosureSEC source: 0001022079-20-000061 · wf-form4_158293029573669.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,977 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 356 | $113.34 | $40,349.04 |
DisclosureSEC source: 0001022079-20-000044 · wf-form4_158275265542037.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,345 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 405 | $112.73 | $45,655.65 |
DisclosureSEC source: 0001022079-20-000044 · wf-form4_158275265542037.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,701 F2 · shares: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 432 | $112.17 | $48,457.44 |
DisclosureSEC source: 0001022079-20-000044 · wf-form4_158275265542037.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,106 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 26,165 | $0.00 Strike: $112.17 | $0.00 |
DisclosureSEC source: 0001022079-20-000027 · wf-form4_158224871364987.xml · derivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,165 Underlying: Common Stock · 26,165 shares Expires 2030-02-18 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 4,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000027 · wf-form4_158224871364987.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,538 F1 · security: Represents an award of restricted share units. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 20:24 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 60,492 | $71.17 Strike: $71.17 | $4,305,215.64 |
DisclosureSEC source: 0001022079-19-000106 · wf-form4_155475508352754.xml · derivative · entry 5 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,492 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 6, 2019. F6 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 20:24 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,890 | $90.59 | $533,586.88 |
DisclosureSEC source: 0001022079-19-000106 · wf-form4_155475508352754.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,526 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 6, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $90.18 to $91.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 20:24 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 60,492 | $90.59 | $5,480,151.76 |
DisclosureSEC source: 0001022079-19-000106 · wf-form4_155475508352754.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,416 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 6, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $90.08 to $91.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 04, 2019 Filed Apr 8, 2019 20:24 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 60,492 | $71.17 | $4,305,215.64 |
DisclosureSEC source: 0001022079-19-000106 · wf-form4_155475508352754.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 6, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 3,777 | $86.86 | $328,070.22 |
DisclosureSEC source: 0001022079-19-000090 · wf-form4_155182133616795.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,416 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 7,669 | $86.86 | $666,129.34 |
DisclosureSEC source: 0001022079-19-000090 · wf-form4_155182133616795.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,193 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 25, 2016, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:19 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,066 | $87.84 | $93,637.44 |
DisclosureSEC source: 0001022079-19-000072 · wf-form4_155139235534627.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,524 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 23:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 363 | $88.24 | $32,031.12 |
DisclosureSEC source: 0001022079-19-000056 · wf-form4_155130990758300.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,590 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.